Intensity Therapeutics
Manufacturing · Connecticut, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1 Enterprise Dr Ste 430, Shelton, Connec...Phone Number
(203) 221-7381Revenue
<$5 MillionStock Symbol
INTSIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Intensity Therapeutics
Intensity Therapeutics is a clinical-stage biotechnology company whose mission is to help patients live longer, higher quality lives by discovering, developing, and commercializing first-in-class cancer drugs that attenuate tumors with minimal side effects, while training the patients own immune system to fight the cancer.Explore more
Intensity Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Intensity Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Intensity Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Intensity Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Intensity Therapeutics
Website visits: Recent activity has been detected on your website
Check if Intensity Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Intensity Therapeutics had a recent Job posting/layoffs
Check out if Intensity Therapeutics is spiking on competitors!
Earning: See what the market has to say on Intensity Therapeutics recently announced quarterly report
Intensity Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Intensity Therapeutics
Find 3 more new buyers
Compare Similar Companies to Intensity Therapeutics
Compare insights from companies similar to Intensity Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
11-50
Private
-
2005
RR
Richard RobbFounder & Vice President, Research, Development & Quality Assurance
Company Profile Activity
Activity Insights
Intensity Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Intensity Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Intensity Therapeutics.
Intensity Therapeutics financials insights
Gather financial insights about Intensity Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Angel/Seed
$1.8M
2015
Private Equity
$500K
2016
Series A
$10M
2018
Series B
$6.5M
2025
Other Financing Round
$6.6M
Intensity Therapeutics Tech Stack
A closer look at the technologies used by Intensity Therapeutics
See more technologies
Most Recent Scoops
Project
Product Development, Product Management, Intellectual Property, Legal Affairs, Software, Pharmaceuticals, Clinical Operations
Person-Based
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Person-Based
Intensity Therapeutics News & Media
Intensity Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Cash and cash equivalents of $10.2 million as of March 31, 2026 Favorable efficacy and safety reported in a small sample of triple negative breast cancer ("TNBC") patients receiving INT230-6 prior to the standard of care ("SOC") compared to SOC alone in the INVINCIBLE-4 Study (as defined...Intensity Therapeutics Recognized with Pinnacle Award for Excellence in Healthcare Innovation
Company receives the Platinum Award for Innovator in Biotech Solutions Category SHELTON, Conn., April 15, 2026 /PRNewswire/ -- Intensity Therapeutics, Inc., (Nasdaq: INTS) ("Intensity" or the "Company"), a late-stage clinical biotechnology company focused on the discovery and development...Intensity Therapeutics Reports 2025 Year End Financial Results and Highlights, and Provides Corporate Update
Raised over $20 million in gross proceeds in 2025 and held $11.9 million in cash and cash equivalents as of December 31, 2025, with a cash runway into the second quarter of 2027 IT-01 Study manuscript of INT230-6 used alone in 64 refractory metastatic cancer patients published in the...Intensity Therapeutics Strengthens IP Portfolio with Issuance of New Patent in the US
New US patent 12,496,345 strengthens the existing portfolio Patents now granted in 41 countries protect the Company's novel intratumoral technology, including lead compound INT230-6 SHELTON, Conn., March 24, 2026 /PRNewswire/ -- Intensity Therapeutics, Inc., (Nasdaq: INTS) ("Intensity" or...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Intensity Therapeutics
Sign Up For FreeTo access detailed company insights
Intensity Therapeutics is a clinical-stage biotechnology company whose mission is to help patients live longer, higher quality lives by discovering, developing, and commercializing first-in-class cancer drugs that attenuate tumors with minimal side effects, while training the patients own immune system to fight the cancer.... Read More
